| pubmed-article:11801708 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11801708 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:11801708 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:11801708 | lifeskim:mentions | umls-concept:C0030193 | lld:lifeskim |
| pubmed-article:11801708 | lifeskim:mentions | umls-concept:C0153690 | lld:lifeskim |
| pubmed-article:11801708 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
| pubmed-article:11801708 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:11801708 | lifeskim:mentions | umls-concept:C0206034 | lld:lifeskim |
| pubmed-article:11801708 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:11801708 | pubmed:dateCreated | 2002-1-21 | lld:pubmed |
| pubmed-article:11801708 | pubmed:abstractText | This study evaluated the effects of low-dose cisplatin plus 89Sr versus 89Sr alone in the treatment of painful bone metastases from prostate cancer, addressing both pain palliation and cytostatic effects. | lld:pubmed |
| pubmed-article:11801708 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11801708 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11801708 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11801708 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11801708 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11801708 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11801708 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11801708 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11801708 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:11801708 | pubmed:issn | 0161-5505 | lld:pubmed |
| pubmed-article:11801708 | pubmed:author | pubmed-author:SciutoRosaR | lld:pubmed |
| pubmed-article:11801708 | pubmed:author | pubmed-author:FestaAnnaA | lld:pubmed |
| pubmed-article:11801708 | pubmed:author | pubmed-author:ReaSandraS | lld:pubmed |
| pubmed-article:11801708 | pubmed:author | pubmed-author:PasqualoniRos... | lld:pubmed |
| pubmed-article:11801708 | pubmed:author | pubmed-author:BergomiSerene... | lld:pubmed |
| pubmed-article:11801708 | pubmed:author | pubmed-author:PetrilliGerma... | lld:pubmed |
| pubmed-article:11801708 | pubmed:author | pubmed-author:MainiCarlo... | lld:pubmed |
| pubmed-article:11801708 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11801708 | pubmed:volume | 43 | lld:pubmed |
| pubmed-article:11801708 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11801708 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11801708 | pubmed:pagination | 79-86 | lld:pubmed |
| pubmed-article:11801708 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11801708 | pubmed:meshHeading | pubmed-meshheading:11801708... | lld:pubmed |
| pubmed-article:11801708 | pubmed:meshHeading | pubmed-meshheading:11801708... | lld:pubmed |
| pubmed-article:11801708 | pubmed:meshHeading | pubmed-meshheading:11801708... | lld:pubmed |
| pubmed-article:11801708 | pubmed:meshHeading | pubmed-meshheading:11801708... | lld:pubmed |
| pubmed-article:11801708 | pubmed:meshHeading | pubmed-meshheading:11801708... | lld:pubmed |
| pubmed-article:11801708 | pubmed:meshHeading | pubmed-meshheading:11801708... | lld:pubmed |
| pubmed-article:11801708 | pubmed:meshHeading | pubmed-meshheading:11801708... | lld:pubmed |
| pubmed-article:11801708 | pubmed:meshHeading | pubmed-meshheading:11801708... | lld:pubmed |
| pubmed-article:11801708 | pubmed:meshHeading | pubmed-meshheading:11801708... | lld:pubmed |
| pubmed-article:11801708 | pubmed:meshHeading | pubmed-meshheading:11801708... | lld:pubmed |
| pubmed-article:11801708 | pubmed:meshHeading | pubmed-meshheading:11801708... | lld:pubmed |
| pubmed-article:11801708 | pubmed:meshHeading | pubmed-meshheading:11801708... | lld:pubmed |
| pubmed-article:11801708 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:11801708 | pubmed:articleTitle | Effects of low-dose cisplatin on 89Sr therapy for painful bone metastases from prostate cancer: a randomized clinical trial. | lld:pubmed |
| pubmed-article:11801708 | pubmed:affiliation | Nuclear Medicine Department, Regina Elena Cancer Institute, Rome, Italy. sciuto@ifo.it | lld:pubmed |
| pubmed-article:11801708 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11801708 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11801708 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:11801708 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:11801708 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11801708 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11801708 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11801708 | lld:pubmed |
